Apr 04, 2023 / 12:30PM GMT
Operator
Good morning, and welcome to the Precigen Business and Clinical Update Conference Call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Steven Harasym, Head of Investor Relations. Please go ahead.
Steven Harasym - Precigen, Inc. - VP & Head of IR
Thank you, Anthony. We are joined today by Dr. Helen Sabzevari, President and CEO of Precigen.
Before we begin, I'd like to remind you that during today's call, we will make various forward-looking statements. Investors are cautioned that our forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ. Please read the safe harbor statement contained on our company filings as well as risk factors in our most recent SEC filings.
Helen, I'd like to turn the call over to you now. Thank you.
Helen Sabzevari - Precigen, Inc. - President, CEO & Director
Thank you, Steve, and thank you
Precigen Inc Business and Clinical Update Call Transcript
Apr 04, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers